Header Logo

Connection

Peter Lindenauer to Anti-Bacterial Agents

Back to Details
This is a "connection" page, showing publications Peter Lindenauer has written about Anti-Bacterial Agents.
Peter Lindenauer
Connection Strength
5.668
Anti-Bacterial Agents
  1. Pulia MS, Griffin M, Schwei R, Pop-Vicas A, Schulz LT, Shieh MS, Pekow P, Vaughn VM, Lindenauer PK. Antibiotic Treatment in Patients Hospitalized for Nonsevere COVID-19. JAMA Netw Open. 2025 05 01; 8(5):e2511499.
    View in: PubMed
    Score: 0.610
  2. Stefan MS, Spitzer KA, Zulfiqar S, Heineman BD, Hogan TP, Westafer LM, Pulia MS, Pinto-Plata VM, Lindenauer PK. Uncertainty as a critical determinant of antibiotic prescribing in patients with an asthma exacerbation: a qualitative study. J Asthma. 2022 Feb; 59(2):352-361.
    View in: PubMed
    Score: 0.448
  3. Pulia MS, Wolf I, Schulz LT, Pop-Vicas A, Schwei RJ, Lindenauer PK. COVID-19: An Emerging Threat to Antibiotic Stewardship in the Emergency Department. West J Emerg Med. 2020 Aug 07; 21(5):1283-1286.
    View in: PubMed
    Score: 0.440
  4. Stefan MS, Shieh MS, Spitzer KA, Pekow PS, Krishnan JA, Au DH, Lindenauer PK. Association of Antibiotic Treatment With Outcomes in Patients Hospitalized for an Asthma Exacerbation Treated With Systemic Corticosteroids. JAMA Intern Med. 2019 03 01; 179(3):333-339.
    View in: PubMed
    Score: 0.398
  5. Lindenauer PK, Shieh MS, Stefan MS, Fisher KA, Haessler SD, Pekow PS, Rothberg MB, Krishnan JA, Walkey AJ. Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for Chronic Obstructive Pulmonary Disease Exacerbation. Ann Am Thorac Soc. 2017 Dec; 14(12):1779-1785.
    View in: PubMed
    Score: 0.365
  6. Lindenauer PK, Stefan MS, Feemster LC, Shieh MS, Carson SS, Au DH, Krishnan JA. Use of Antibiotics Among Patients Hospitalized for Exacerbations of Asthma. JAMA Intern Med. 2016 09 01; 176(9):1397-400.
    View in: PubMed
    Score: 0.335
  7. Rothberg MB, Zilberberg MD, Pekow PS, Priya A, Haessler S, Belforti R, Skiest D, Lagu T, Higgins TL, Lindenauer PK. Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia. J Antimicrob Chemother. 2015 May; 70(5):1573-9.
    View in: PubMed
    Score: 0.298
  8. Leyenaar JK, Lagu T, Shieh MS, Pekow PS, Lindenauer PK. Management and outcomes of pneumonia among children with complex chronic conditions. Pediatr Infect Dis J. 2014 Sep; 33(9):907-11.
    View in: PubMed
    Score: 0.291
  9. Leyenaar JK, Lagu T, Shieh MS, Pekow PS, Lindenauer PK. Variation in resource utilization for the management of uncomplicated community-acquired pneumonia across community and children's hospitals. J Pediatr. 2014 Sep; 165(3):585-91.
    View in: PubMed
    Score: 0.288
  10. Leyenaar JK, Shieh MS, Lagu T, Pekow PS, Lindenauer PK. Comparative effectiveness of ceftriaxone in combination with a macrolide compared with ceftriaxone alone for pediatric patients hospitalized with community-acquired pneumonia. Pediatr Infect Dis J. 2014 Apr; 33(4):387-92.
    View in: PubMed
    Score: 0.283
  11. Stefan MS, Lindenauer PK. Response. Chest. 2013 Aug; 144(2):716-717.
    View in: PubMed
    Score: 0.270
  12. Stefan MS, Rothberg MB, Shieh MS, Pekow PS, Lindenauer PK. Association between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroids. Chest. 2013 Jan; 143(1):82-90.
    View in: PubMed
    Score: 0.260
  13. Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA. 2010 May 26; 303(20):2035-42.
    View in: PubMed
    Score: 0.217
  14. Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Comparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). J Hosp Med. 2010 May-Jun; 5(5):261-7.
    View in: PubMed
    Score: 0.216
  15. Vaughn VM, Horowitz J, Gandhi T, Neetz RA, Petty L, Hersh A, Lindenauer P, Bernstein SJ, Flanders SA, Harrison JD, Smith JD, White AT, Szymczak JE. Developing an approach to enhance recruitment for a cluster-randomised implementation trial: leveraging deliberative participation and credible messengers. BMJ Open. 2025 Sep 16; 15(9):e094925.
    View in: PubMed
    Score: 0.157
  16. Jewell MJ, Leyenaar J, Shieh MS, Pekow PS, Stefan M, Lindenauer PK. Unnecessary antibiotic prescribing in children hospitalised for asthma exacerbation: a retrospective national cohort study. BMJ Qual Saf. 2021 04; 30(4):292-299.
    View in: PubMed
    Score: 0.108
  17. Walkey AJ, Shieh MS, Liu VX, Lindenauer PK. Mortality Measures to Profile Hospital Performance for Patients With Septic Shock. Crit Care Med. 2018 08; 46(8):1247-1254.
    View in: PubMed
    Score: 0.096
  18. Haessler S, Lagu T, Lindenauer PK, Skiest DJ, Priya A, Pekow PS, Zilberberg MD, Higgins TL, Rothberg MB. Treatment Trends and Outcomes in Healthcare-Associated Pneumonia. J Hosp Med. 2017 11; 12(11):886-891.
    View in: PubMed
    Score: 0.091
  19. Belforti RK, Lagu T, Haessler S, Lindenauer PK, Pekow PS, Priya A, Zilberberg MD, Skiest D, Higgins TL, Stefan MS, Rothberg MB. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia. Clin Infect Dis. 2016 07 01; 63(1):1-9.
    View in: PubMed
    Score: 0.081
  20. Lindenauer PK, Rothberg MB, Nathanson BH, Pekow PS, Steingrub JS. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis. Crit Care Med. 2010 Apr; 38(4):1101-7.
    View in: PubMed
    Score: 0.054
  21. Lindenauer PK, Behal R, Murray CK, Nsa W, Houck PM, Bratzler DW. Volume, quality of care, and outcome in pneumonia. Ann Intern Med. 2006 Feb 21; 144(4):262-9.
    View in: PubMed
    Score: 0.040
  22. Szymczak JE, Petty LA, Gandhi TN, Neetz RA, Hersh A, Presson AP, Lindenauer PK, Bernstein SJ, Muller BM, White AT, Horowitz JK, Flanders SA, Smith JD, Vaughn VM. Protocol for a parallel cluster randomized trial of a participatory tailored approach to reduce overuse of antibiotics at hospital discharge: the ROAD home trial. Implement Sci. 2024 03 04; 19(1):23.
    View in: PubMed
    Score: 0.035
  23. Deshpande A, Klompas M, Guo N, Imrey PB, Pallotta AM, Higgins T, Haessler S, Zilberberg MD, Lindenauer PK, Rothberg MB. Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia. Clin Infect Dis. 2023 07 26; 77(2):174-185.
    View in: PubMed
    Score: 0.034
  24. Rothberg MB, Haessler S, Deshpande A, Yu PC, Lindenauer PK, Zilberberg MD, Higgins TL, Imrey PB. Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia. Infect Control Hosp Epidemiol. 2023 07; 44(7):1143-1150.
    View in: PubMed
    Score: 0.032
  25. Patel P, Deshpande A, Yu PC, Imrey PB, Lindenauer PK, Zilberberg MD, Haessler S, Rothberg MB. Association of fluoroquinolones or cephalosporin plus macrolide with Clostridioides difficile infection (CDI) after treatment for community-acquired pneumonia. Infect Control Hosp Epidemiol. 2023 01; 44(1):47-54.
    View in: PubMed
    Score: 0.031
  26. Haessler S, Guo N, Deshpande A, Zilberberg MD, Lagu T, Lindenauer PK, Imrey PB, Rothberg MB. Etiology, Treatments, and Outcomes of Patients With Severe Community-Acquired Pneumonia in a Large U.S. Sample. Crit Care Med. 2022 07 01; 50(7):1063-1071.
    View in: PubMed
    Score: 0.031
  27. Deshpande A, Klompas M, Yu PC, Imrey PB, Pallotta AM, Higgins T, Haessler S, Zilberberg MD, Lindenauer PK, Rothberg MB. Influenza Testing and Treatment Among Patients Hospitalized With Community-Acquired Pneumonia. Chest. 2022 09; 162(3):543-555.
    View in: PubMed
    Score: 0.030
  28. Deshpande A, Richter SS, Haessler S, Lindenauer PK, Yu PC, Zilberberg MD, Imrey PB, Higgins T, Rothberg MB. De-escalation of Empiric Antibiotics Following Negative Cultures in Hospitalized Patients With Pneumonia: Rates and Outcomes. Clin Infect Dis. 2021 04 26; 72(8):1314-1322.
    View in: PubMed
    Score: 0.029
  29. Haessler S, Lindenauer PK, Zilberberg MD, Imrey PB, Yu PC, Higgins T, Deshpande A, Rothberg MB. Blood Cultures Versus Respiratory Cultures: 2 Different Views of Pneumonia. Clin Infect Dis. 2020 10 23; 71(7):1604-1612.
    View in: PubMed
    Score: 0.028
  30. Schimmel JJ, Haessler S, Imrey P, Lindenauer PK, Richter SS, Yu PC, Rothberg MB. Pneumococcal Urinary Antigen Testing in United States Hospitals: A Missed Opportunity for Antimicrobial Stewardship. Clin Infect Dis. 2020 09 12; 71(6):1427-1434.
    View in: PubMed
    Score: 0.028
  31. Gupta NM, Lindenauer PK, Yu PC, Imrey PB, Haessler S, Deshpande A, Higgins TL, Rothberg MB. Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia. JAMA Netw Open. 2019 06 05; 2(6):e195172.
    View in: PubMed
    Score: 0.025
  32. Dharmarajan K, Strait KM, Tinetti ME, Lagu T, Lindenauer PK, Lynn J, Krukas MR, Ernst FR, Li SX, Krumholz HM. Treatment for Multiple Acute Cardiopulmonary Conditions in Older Adults Hospitalized with Pneumonia, Chronic Obstructive Pulmonary Disease, or Heart Failure. J Am Geriatr Soc. 2016 08; 64(8):1574-82.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.